Hantavirus Vaccine: Moderna Has Been Developing a Vaccine Since 2023 in Collaboration with a Korean University

Hantavirus Vaccine: Moderna Has Been Developing a Vaccine Since 2023 in Collaboration with a Korean University

The deadly hantavirus outbreak linked to the cruise ship MV Hondius has reignited global interest in vaccines against one of the world's most feared rodent-borne diseases, with Moderna emerging as a key player in an experimental new mRNA-based shot. The outbreak, tied to the Andes virus strain, the only hantavirus known to spread between humans, has left multiple passengers dead and several others infected after the MV Hondius sailed from Argent…

Moderna Stock Surges on Hantavirus Vaccine News as Cruise Outbreak Puts mRNA Pipeline Back in Focus

Moderna shares rose about 10% Friday after the company announced research into vaccines for hantaviruses amid a deadly Andes virus outbreak linked to the MV Hondius cruise ship. WHO reported eight cases and three deaths, with five confirmed as hantavirus. Moderna’s vaccine program is in early stages, with commercial availability still years away. The U.S. is arranging a repatriation flight for 17 Americans from the ship. The post Moderna Stock S…